Insider Transactions Reported by 11 Insiders of HUMANIGEN, INC

Location: Short Hills, NJ

Quick Takeaways

HUMANIGEN, INC has 11 insiders with reported activity on this page.
No net insider buy/sell flow is currently reported for the last year.
Recent transaction rows are not currently available.

What Changed

No meaningful buy/sell imbalance is currently visible in the one-year window.
Activity will update as new Forms 3/4/5 are filed.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 19 Apr 2025.

Buys

Shares: 0

Insiders: 0

Sells

Shares: 0

Insiders: 0

Net

Shares: 0

Insiders: 0

Window (months)	Buy $	Sell $	Net $
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

HUMANIGEN, INC executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Valuation	Report Date
Cameron Durrant	Chief Executive Officer, Director	$3,664,344	Mixed	27 Jul 2022
Timothy E. Morris	COO and CFO	$2,719,631	Mixed	27 Jul 2022
Adrian Kilcoyne	Chief Medical Officer	$2,433,353	Mixed	27 Jul 2022
Edward P. Jordan	Chief Commercial Officer	$2,061,195	Mixed	27 Jul 2022
NOMIS BAY LTD.	10%+ Owner	$612,742	Mixed	31 Dec 2020
Yili Kevin Xie	Director	$377,884	Mixed	27 Jul 2022
Cheryl Buxton	Director	$354,980	Mixed	27 Jul 2022
Rainer J. Boehm	Director	$332,081	Mixed	27 Jul 2022
John Hohneker	Director	$286,273	Mixed	27 Jul 2022
Ronald Barliant	Director	$251,922	Mixed	27 Jul 2022
Dale Chappell	Chief Scientific Officer, Director, 10%+ Owner	$129,228	Filing P/S	18 Oct 2023

Top shareholders of HUMANIGEN, INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Cameron Durrant	3/4/5	Chief Executive Officer, Director	— class O/S missing	808,906	$3,664,344	—	27 Jul 2022	3/4/5
Timothy E. Morris	3/4/5	COO and CFO	— class O/S missing	600,360	$2,719,631	—	27 Jul 2022	3/4/5
Adrian Kilcoyne	3/4/5	Chief Medical Officer	— class O/S missing	537,164	$2,433,353	—	27 Jul 2022	3/4/5
Edward P. Jordan	3/4/5	Chief Commercial Officer	— class O/S missing	455,010	$2,061,195	—	27 Jul 2022	3/4/5
NOMIS BAY LTD.	3/4/5	10%+ Owner	— class O/S missing	6,532,433	$612,742	—	31 Dec 2020	3/4/5
Yili Kevin Xie	3/4/5	Director	— class O/S missing	83,418	$377,884	—	27 Jul 2022	3/4/5
Cheryl Buxton	3/4/5	Director	— class O/S missing	78,362	$354,980	—	27 Jul 2022	3/4/5
Rainer J. Boehm	3/4/5	Director	— class O/S missing	73,307	$332,081	—	27 Jul 2022	3/4/5
John Hohneker	3/4/5	Director	— class O/S missing	63,195	$286,273	—	27 Jul 2022	3/4/5
Ronald Barliant	3/4/5	Director	— class O/S missing	55,612	$251,922	—	27 Jul 2022	3/4/5
Dale Chappell	3/4/5	Chief Scientific Officer, Director, 10%+ Owner	— class O/S missing	11,747,937	$129,228	—	18 Oct 2023	3/4/5

Recent Insider Transactions by Companies or Individuals for HUMANIGEN, INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.